Plain-English translation of NCT06138561 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study is watching how older adults with advanced bladder cancer respond to different treatment options when they cannot receive cisplatin (a strong chemotherapy drug). Researchers will track your side effects, quality of life, and how well your cancer responds to treatment over 8 months. The study is also testing whether a simple 8-question health survey can help doctors predict which patients will do better with different treatments.
Many older adults with advanced bladder cancer have other health conditions that make cisplatin too risky, but doctors aren't sure which alternative treatments work best for them. This study aims to find the safest and most effective approach for this group and to develop better tools to match each patient with the right treatment.
You likely qualify if…
You likely don't qualify if…
You will start with a baseline visit to complete health questionnaires, then answer follow-up surveys every 3 weeks for 8 months by phone or in-person visits. You will continue receiving your regular cancer treatment from your doctor as planned. After the main study ends, you have the option to participate in brief follow-up phone calls every 6 months for up to 3 more years to track your long-term outcomes.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
United States